Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Acugout - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Acugout

Approved

STANDARD

Acugout

Flamingo Pharmaceuticals Ltd🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 0851ad48671ffd10
Company: Flamingo Pharmaceuticals Ltd
Type: Standard

Approval Details

Approval Id: 0851ad48671ffd10
Drug Approval Philippines Name: Acugout
Product Name: Acugout
Registration Number: DRP-10372-01
Brand Name: Acugout
Generic Name: Colchicine
Dosage Form: Tablet
Dosage Strength: 500 mcg
Manufacturer: Flamingo Pharmaceuticals Ltd
Importer: Hexagon Pharmaceuticals
Distributor: Trumed Pharmaceuticals
Issuance Date: 24 October 2022
Expiry Date: 26 November 2027
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

0851ad48671ffd10

Type

Standard

Back to Philippines FDA Approvals